Location History:
- Cazarzere, IT (2021)
- Villadose, IT (2022)
- Cassina de' Pecchi, IT (2023)
Company Filing History:
Years Active: 2021-2024
Title: Andrea Orlandin: Innovator in Peptide Manufacturing
Introduction
Andrea Orlandin is a distinguished inventor based in Villadose, Italy. She has made significant contributions to the field of peptide manufacturing, holding a total of 4 patents. Her innovative approaches have advanced the processes involved in creating essential peptides used in various medical applications.
Latest Patents
One of her latest patents is titled "Process for the manufacture of degarelix and its intermediates." This invention outlines a manufacturing process for preparing a peptide, specifically a decapeptide like degarelix, by incorporating p-nitro-phenylalanin into the amino acid sequence during stepwise solid phase synthesis. The process also includes converting these into the required amino acids Aph(Hor) and/or D-Aph(Cbm), preferably while attached to a solid phase. Additionally, she has developed a patent for "Process for the preparation of high purity glucagon." This improved process utilizes Xmb-protected amino acids, which may include compounds such as 2,4,6-trimethoxybenzyl, 2,4-dimethoxybenzyl, or 2-hydroxy-4-methoxybenzyl. The method also incorporates building blocks like pseudoprolines to prevent aggregation and achieve high yield and purity of the product.
Career Highlights
Throughout her career, Andrea has worked with notable companies, including Fresenius Kabi Ipsum S.r.l. and Fresenius Kabi Ipsum S.r.l. Her expertise in peptide synthesis has positioned her as a key player in the pharmaceutical industry.
Collaborations
Andrea has collaborated with esteemed colleagues such as Antonio Ricci and Walter Cabri. These partnerships have further enriched her research and development efforts in peptide manufacturing.
Conclusion
Andrea Orlandin's innovative work in peptide manufacturing has led to significant advancements in the field. Her contributions continue to impact the pharmaceutical industry positively, showcasing her dedication to scientific progress.